Discussing The Past, Present And Future Of Cell And Gene Therapies
Outgoing CEO Of The Cell and Gene Therapy Catapult, Keith Thompson, On Turning Groundbreaking Research Into A New Industry
Executive Summary
Founding CEO of the UK’s Cell and Gene Therapy Catapult, Keith Thompson, will retire from the company this year. He looks back on the last eight years of progress for CGT Catapult and the advanced therapies sector – and provides words of wisdom for the challenges still to come.